The trick: Self-Marked
The 42.9% is 36 people.
All 84 in the study were screened at Biograph, and every author works for Biograph.
AI analysis of CT scans finds 42.9% of patients have coronary inflammation.
Before you read on. Your call?
TRUE, BUT
36
The figure is 36 of 84 symptom-free adults screened at Biograph, in a Biograph-sponsored preprint written by Biograph employees. It measures a score above the 75th percentile, not heart attacks.
There’s more to this story.
Membership opens the full investigation, the strongest counterargument and what to do with what you’ve learned.
30 days free, then A$89 a year. Payment card required. Cancel before the trial ends to avoid the first charge.
Review my 30-day free trial →- At sign-up: 30 days free. Payment card required. One introductory trial per customer.
- Your trial ends 30 days after you start. Unless you cancel before then in Account → Manage subscription, we charge A$89 for the first year. It renews automatically at A$89/yr until cancelled.
- You can ask for a full refund within 14 days after any annual payment, renewals included, with no reason needed, by emailing hello@bskiller.com. This voluntary refund does not limit your rights under the Australian Consumer Law.
By starting your trial, you agree to the Terms.
BS Killer is published by Inferno Tech Pty Ltd, ABN 27 647 413 474.
Get tomorrow’s check free by email.
Couldn't check your access. That's on us.
The trick has a name
We call it Self-Marked: graded by the party that benefits from the grade. You'll see it again. Learn to spot it →
Receipts
- Supports medrxiv.org:
Elevated FAI-Score (≥75th percentile) was present in 42.9% of participants (36/84; 95% CI 32.8% - 53.5%)
- Context medrxiv.org:
84 consecutive asymptomatic adults (mean age 53.7 ± 8.6 years; 63.1% men) with no prior coronary artery disease underwent screening CCTA
- Refutes medrxiv.org:
all authors (DS, JF, MN, MD) are employees of Biograph and may hold stock or stock options in the company
- Refutes medrxiv.org:
received financial support from Biograph for the submitted work as employees of Biograph, which sponsored the study
- Context medrxiv.org:
quantifies vascular inflammation and predicts cardiac mortality in symptomatic cohorts
- Context medrxiv.org:
its prevalence, anatomical distribution, and clinical correlates in asymptomatic primary prevention populations remain uncharacterized
- Refutes medrxiv.org:
Systemic hs-CRP (median 0.8 mg/L) exhibited an inverse correlation with maximum vessel FAI-Score (Spearman ρ=−0.27, p=0.014)
- Context biograph.com:
The study, available to clinically eligible Biograph Black tier members
- Supports biograph.com:
showed no correlation with the presence of coronary inflammation and failed to identify which patients had inflamed arteries
- Supports biograph.com:
The study found that coronary inflammation is common (42.9%) in asymptomatic, low-risk adults
- Context hcplive.com:
Caristo's De Novo submission drew on validation data from large independent populations published in The Lancet
Open the Receipts Pack → What each source proves, every figure traced, and what would change our verdict.
